Dictionary
The Dictionary provides concise definitions of health economics terms, arranged alphabetically for quick reference. Use it to understand unfamiliar terminology or confirm the meaning of a specific term.
D
- Data Collection RequirementEvidence Generation Requirement, Data Requirement
- A condition attached to a conditional reimbursement decision, mandating collection of additional real-world performance data within a defined timeframe.
E
- External Reference PricingERP, Cross-Country Reference Pricing
- A medicine-pricing policy that uses prices for the same or comparable product in other jurisdictions as benchmarks for a domestic price or reimbursement decision.
H
- HASHaute Autorite de Sante, French National Authority for Health
- The French National Authority for Health, conducting assessment including SMR and ASMR ratings that inform pricing and reimbursement decisions.
N
- National HTA AgencyNational HTA Body, HTA Agency
- A government or government-mandated organisation conducting assessment to inform coverage, pricing, and reimbursement decisions within a country's health system.
- NCPENational Centre for Pharmacoeconomics, Irish HTA Agency
- The National Centre for Pharmacoeconomics, Ireland's body conducting pharmaceutical assessment to inform national reimbursement decisions.
P
- Pharmacoeconomic ModelPE Model, Pharmacoeconomic Evaluation Model
- A decision-analytic model built specifically to evaluate the cost and outcomes of pharmaceutical treatments, typically supporting pricing and reimbursement decisions.
R
- Registry RequirementMandatory Registry Enrolment, Post-Approval Data Duty
- A condition attached to a conditional reimbursement decision, mandating patients be enrolled in a data collection registry to generate further evidence.
- Reimbursement DecisionCoverage Verdict, Reimbursement Verdict
- The formal determination by a payer regarding whether, and under what conditions, a technology will be financially covered for a population.